Cargando…
Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study
BACKGROUND: The efficacy of medical treatment among obese men with lower urinary tract symptoms (LUTS) has been less clear, especially regarding the improvement of QoL. We aimed to investigate the difference in efficacy and consequent satisfaction of life quality after medical treatment of male LUTS...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126641/ https://www.ncbi.nlm.nih.gov/pubmed/25099073 http://dx.doi.org/10.1186/1471-2490-14-60 |
_version_ | 1782329939129794560 |
---|---|
author | Kim, Jae Heon Choi, Hoon Sun, Hwa Yeon Doo, Seung Whan Yoon, Jong Hyun Yang, Won Jae Yoo, Byung Wook Kim, Joyce Mary Kwon, Soon-Sun Song, Eun Seop Lee, Hong Jun Lim, Ik Sung Song, Yun Seob |
author_facet | Kim, Jae Heon Choi, Hoon Sun, Hwa Yeon Doo, Seung Whan Yoon, Jong Hyun Yang, Won Jae Yoo, Byung Wook Kim, Joyce Mary Kwon, Soon-Sun Song, Eun Seop Lee, Hong Jun Lim, Ik Sung Song, Yun Seob |
author_sort | Kim, Jae Heon |
collection | PubMed |
description | BACKGROUND: The efficacy of medical treatment among obese men with lower urinary tract symptoms (LUTS) has been less clear, especially regarding the improvement of QoL. We aimed to investigate the difference in efficacy and consequent satisfaction of life quality after medical treatment of male LUTS according to obesity. METHODS: An 8-week prospective study was performed for a total of 140 patients >50 years old with International Prostate Symptom Scores (IPSS) > 12 points and prostate volume > 20 mL. Obesity was determined by either body mass index (BMI) or waist circumference (WC). Patients were divided into 2 groups according to BMI or WC. Patients received tamsulosin at a dose of 0.4 mg daily for 8 weeks. The changes from baseline in the IPSS, maximal urinary flow rate (Qmax), post-void residual volume, questionnaire of quality of life (QoL), and King’s Health Questionnaire (KHQ) were analyzed. RESULTS: Of the 150 enrolled patients, 96 completed the study. Seventy-five patients (78.1%) had BMI ≥ 23 kg/m(2), and 24 (25.0%) had WC > 90 cm. Overall, the IPSS, IPSS QoL, and total KHQ showed significant improvement. Obese (BMI ≥ 23 kg/m(2)) and non-obese (BMI < 23 kg/m(2)) both showed improvement of the IPSS and IPSS QoL scores, but only the obese (BMI ≥ 23 kg/m(2)) group showed improvement of the total KHQ score (P < 0.001 vs. P = 0.55). Only the obese (WC > 90 cm) group showed improvement of the IPSS and total KHQ scores (P < 0.001). CONCLUSIONS: Our preliminary study showed the different efficacy of an alpha-blocker for improvement of LUTS and life quality according to obesity. Obese patients, defined by BMI or WC, showed the tendency toward a more favorable improvement of LUTS and life quality. TRIAL REGISTRATION: Current Controlled Trials 2010–058. Registered 2 September 2010 in Soonchunhyang Univeristy Hospital |
format | Online Article Text |
id | pubmed-4126641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41266412014-08-09 Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study Kim, Jae Heon Choi, Hoon Sun, Hwa Yeon Doo, Seung Whan Yoon, Jong Hyun Yang, Won Jae Yoo, Byung Wook Kim, Joyce Mary Kwon, Soon-Sun Song, Eun Seop Lee, Hong Jun Lim, Ik Sung Song, Yun Seob BMC Urol Research Article BACKGROUND: The efficacy of medical treatment among obese men with lower urinary tract symptoms (LUTS) has been less clear, especially regarding the improvement of QoL. We aimed to investigate the difference in efficacy and consequent satisfaction of life quality after medical treatment of male LUTS according to obesity. METHODS: An 8-week prospective study was performed for a total of 140 patients >50 years old with International Prostate Symptom Scores (IPSS) > 12 points and prostate volume > 20 mL. Obesity was determined by either body mass index (BMI) or waist circumference (WC). Patients were divided into 2 groups according to BMI or WC. Patients received tamsulosin at a dose of 0.4 mg daily for 8 weeks. The changes from baseline in the IPSS, maximal urinary flow rate (Qmax), post-void residual volume, questionnaire of quality of life (QoL), and King’s Health Questionnaire (KHQ) were analyzed. RESULTS: Of the 150 enrolled patients, 96 completed the study. Seventy-five patients (78.1%) had BMI ≥ 23 kg/m(2), and 24 (25.0%) had WC > 90 cm. Overall, the IPSS, IPSS QoL, and total KHQ showed significant improvement. Obese (BMI ≥ 23 kg/m(2)) and non-obese (BMI < 23 kg/m(2)) both showed improvement of the IPSS and IPSS QoL scores, but only the obese (BMI ≥ 23 kg/m(2)) group showed improvement of the total KHQ score (P < 0.001 vs. P = 0.55). Only the obese (WC > 90 cm) group showed improvement of the IPSS and total KHQ scores (P < 0.001). CONCLUSIONS: Our preliminary study showed the different efficacy of an alpha-blocker for improvement of LUTS and life quality according to obesity. Obese patients, defined by BMI or WC, showed the tendency toward a more favorable improvement of LUTS and life quality. TRIAL REGISTRATION: Current Controlled Trials 2010–058. Registered 2 September 2010 in Soonchunhyang Univeristy Hospital BioMed Central 2014-08-06 /pmc/articles/PMC4126641/ /pubmed/25099073 http://dx.doi.org/10.1186/1471-2490-14-60 Text en Copyright © 2014 Kim et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Kim, Jae Heon Choi, Hoon Sun, Hwa Yeon Doo, Seung Whan Yoon, Jong Hyun Yang, Won Jae Yoo, Byung Wook Kim, Joyce Mary Kwon, Soon-Sun Song, Eun Seop Lee, Hong Jun Lim, Ik Sung Song, Yun Seob Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study |
title | Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study |
title_full | Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study |
title_fullStr | Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study |
title_full_unstemmed | Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study |
title_short | Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study |
title_sort | measuring the improvement in health-related quality of life using king’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126641/ https://www.ncbi.nlm.nih.gov/pubmed/25099073 http://dx.doi.org/10.1186/1471-2490-14-60 |
work_keys_str_mv | AT kimjaeheon measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy AT choihoon measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy AT sunhwayeon measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy AT dooseungwhan measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy AT yoonjonghyun measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy AT yangwonjae measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy AT yoobyungwook measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy AT kimjoycemary measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy AT kwonsoonsun measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy AT songeunseop measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy AT leehongjun measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy AT limiksung measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy AT songyunseob measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy |